| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $850K | — |
| R&D Expense | $42.3M | +11.1% |
| SG&A Expense | $15.1M | +23.6% |
| Operating Income | -$56.6M | -12.4% |
| Income Tax | $0 | — |
| Net Income | -$49.4M | -16.2% |
| EPS (Basic) | -$0.36 | -9.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $43.5M | +79.5% |
| Short-term Investments | $83.2M | -35.1% |
| Current Assets | $132.8M | -13.7% |
| Total Assets | $140.4M | -10.5% |
| Current Liabilities | $8.9M | +13.8% |
| Total Liabilities | $15.2M | +82.0% |
| Stockholders' Equity | $125.2M | -15.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$44.9M | -10.4% |
| Capital Expenditures | $44K | +46.7% |
| Investing Cash Flow | $46.8M | +73.5% |
| Financing Cash Flow | $17.3M | +490.7% |
| Free Cash Flow | -$44.9M | -10.5% |